Trial intelligence / Profile preview

Phase III study of BI 207127 + faldaprevir + ribavirin vs telaprevir + peginterferon + ribavirin in chronic hepatitis C

2012-004544-30Phase 3Completed

Sponsor

Boehringer Ingelheim

Start

Feb 2013

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1